ArticleUrology annals

The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study.

Yasushi Tanuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.